Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
News
Adding oxaliplatin improves OS, DFS in MSI colon cancer
- Author:
- Sharon Worcester
Adding oxaliplatin to fluoropyrimidine should be the standard of care adjuvant treatment in this setting....
News
Poor survival with COVID in patients who have had HSCT
- Author:
- Sharon Worcester
The probability of survival 30 days after being diagnosed with COVID-19 is only 68% for persons who have...
News
Study: Gynecologic cancer therapy does not increase COVID-19 risks
- Author:
- Sharon Worcester
Recent anticancer therapy was not associated with COVID-19 hospitalization or mortality in patients with...
News
Intervention reduced racial disparities among patients in cancer trials
- Author:
- Sharon Worcester
A navigation program improved outcomes of Black women with endometrial cancer enrolled in clinical trials.
News
Andecaliximab disappoints in advanced gastric cancer
- Author:
- Sharon Worcester
There was no improvement in survival when andecaliximab was added to first-line treatment with modified oxaliplatin, leucovorin, and fluorouracil...
News
Breast cancer mortality in under 40s resparks screening debate
- Author:
- Sharon Worcester
An increase in breast cancer mortality among women younger than 40 highlights the value of regular screening,...
News
New ASH guidelines: VTE prevention and treatment in cancer patients
- Author:
- Sharon Worcester
The purpose of the guidelines is to provide clinical decision support for shared decision-making by cancer...
News
Detailed glioblastoma map could lead to better treatment approaches
- Author:
- Sharon Worcester
The identification of multiple glioblastoma tumor subtypes may explain negative findings in trials of...
News
Pap test/cervical swab samples can reveal ovarian cancer biomarkers
- Author:
- Sharon Worcester
Pap test screening is widely accepted, suggesting the value of developing it as a screening tool for both...
News
Novel ddPCR assay precisely measures CAR T-cells after infusion
- Author:
- Sharon Worcester
The ddPCR assay is particularly useful for assessing whether low CAR T-cell levels on flow cytometry are...
News
CAR T-cell products shine in real-world setting, reveal new insights
- Author:
- Sharon Worcester
Real-world CAR-T experience provides new insights for predicting outcomes in patients with DLBCL.
News
TITAN: Final results confirm apalutamide benefit in mCSPC
- Author:
- Sharon Worcester
Apalutamide reduced the risk of death by 35% overall and 48% when accounting for crossover.
News
Declines in PSA screening may account for rise in metastatic prostate cancers
- Author:
- Sharon Worcester
Longitudinal reductions in PSA screening across U.S. states were associated with increased incidence of metastatic prostate cancer.
News
FDA okays new CAR T-cell treatment for large B-cell lymphomas
- Author:
- Sharon Worcester
The Food and Drug Administration has approved lisocabtagene maraleucel (Breyanzi), a chimeric antigen receptor (...
News
FDA grants MET inhibitor tepotinib accelerated approval for NSCLC
- Author:
- Sharon Worcester
Tepotinib is the first once-daily oral MET inhibitor approved for this patient population.